Literature DB >> 20569688

Pharma's developing interest in stem cells.

Ruth McKernan1, John McNeish, Devyn Smith.   

Abstract

Human stem cell biology is driving the promise of novel regenerative therapies into clinical trials. Although the pharmaceutical industry has embraced stem cells as tools in drug discovery, few companies have taken the risk to deliver stem cell-based medicines. Here, we evaluate the various cell-based opportunities and corporate strategies. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20569688     DOI： 10.1016/j.stem.2010.05.012

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  11 in total

1.  Geron trial resumes, but standards for stem cell trials remain elusive.

Authors:  Stephen Strauss
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

2.  Towards expansion of human hair follicle stem cells in vitro.

Authors:  J H Oh; P Mohebi; D L Farkas; J Tajbakhsh
Journal:  Cell Prolif       Date:  2011-06       Impact factor: 6.831

Review 3.  Regenerative medicine: transforming the drug discovery and development paradigm.

Authors:  Sotirios K Karathanasis
Journal:  Cold Spring Harb Perspect Med       Date:  2014-08-01       Impact factor: 6.915

Review 4.  Adipose-derived stem cell secretome as a cell-free product for cutaneous wound healing.

Authors:  Amita Ajit; Indu Ambika Gopalankutty
Journal:  3 Biotech       Date:  2021-08-16       Impact factor: 2.893

5.  The Alpha Stem Cell Clinic: a model for evaluating and delivering stem cell-based therapies.

Authors:  Alan Trounson; Natalie D DeWitt; Ellen G Feigal
Journal:  Stem Cells Transl Med       Date:  2012-01       Impact factor: 6.940

Review 6.  Clinical trials for stem cell therapies.

Authors:  Alan Trounson; Rahul G Thakar; Geoff Lomax; Don Gibbons
Journal:  BMC Med       Date:  2011-05-10       Impact factor: 8.775

7.  From banking to international governance: fostering innovation in stem cell research.

Authors:  Rosario Isasi; Bartha M Knoppers
Journal:  Stem Cells Int       Date:  2011-09-05       Impact factor: 5.443

8.  Microfabricated modular scale-down device for regenerative medicine process development.

Authors:  Marcel Reichen; Rhys J Macown; Nicolas Jaccard; Alexandre Super; Ludmila Ruban; Lewis D Griffin; Farlan S Veraitch; Nicolas Szita
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

9.  Advanced health biotechnologies in Thailand: redefining policy directions.

Authors:  Román Pérez Velasco; Usa Chaikledkaew; Chaw Yin Myint; Roongnapa Khampang; Sripen Tantivess; Yot Teerawattananon
Journal:  J Transl Med       Date:  2013-01-02       Impact factor: 5.531

Review 10.  Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus.

Authors:  Grace C Davey; Swapnil B Patil; Aonghus O'Loughlin; Timothy O'Brien
Journal:  Front Endocrinol (Lausanne)       Date:  2014-06-06       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.